CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
+1.13%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$1.07B
AUM Growth
+$1.07B
(+17%)
Cap. Flow
+$170M
Cap. Flow
% of AUM
15.9%
Top 10 Holdings %
Top 10 Hldgs %
64.66%
Holding
34
New
5
Increased
13
Reduced
3
Closed
3
Top Buys
| 1 |
Codexis
CDXS
|
$52M |
| 2 |
NVTA
Invitae Corporation
NVTA
|
$38.5M |
| 3 |
Adaptive Biotechnologies
ADPT
|
$20.1M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$14.9M |
| 5 |
Twist Bioscience
TWST
|
$8.7M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$9.24M |
| 2 |
Evolent Health
EVH
|
$6.92M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$5.65M |
| 4 |
Gilead Sciences
GILD
|
$5.2M |
| 5 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$1.7M |
Sector Composition
| 1 | Healthcare | 81.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Twist Bioscience
TWST
$1.63B
| $8.7M | 0.81% | +300,000 | New | +$8.7M |
|
27
Denali Therapeutics
DNLI
$2.23B
| $8.3M | 0.78% | 400,000 +300,000 | +300% | +$6.23M |
|
28
CareDx
CDNA
$727M
| $7.2M | 0.67% | 200,000 | – | – |
|
29
Stoke Therapeutics
STOK
$1.08B
| $2.48M | 0.23% | +85,000 | New | +$2.48M |
|
|
TPTX
30
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.44M | 0.23% | +60,000 | New | +$2.44M |
|
|
ORTX
31
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.4M | 0.13% | +100,000 | New | +$1.4M |
|
|
32
Evolent Health
EVH
$1.12B
| – | – | -550,000 | Closed | -$6.92M |
|
|
33
Gilead Sciences
GILD
$140B
| – | – | -80,000 | Closed | -$5.2M |
|
|
ONC
34
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| – | – | -70,000 | Closed | -$9.24M |
|